247 related articles for article (PubMed ID: 15995816)
1. Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development.
Seki M; Yanagisawa A; Ninomiya E; Ninomiya Y; Ohta H; Saiura A; Yamamoto J; Yamaguchi T; Aruga A; Yamada K; Takano K; Fujita R; Ikeda M; Sasaki K; Kato Y
J Hepatobiliary Pancreat Surg; 2005; 12(3):254-62. PubMed ID: 15995816
[TBL] [Abstract][Full Text] [Related]
2. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
3. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
4. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Nagai M; Watanabe M; Iwase T; Yamao K; Isaji S
World J Surg; 2002 Jan; 26(1):91-8. PubMed ID: 11898040
[TBL] [Abstract][Full Text] [Related]
5. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
[TBL] [Abstract][Full Text] [Related]
7. Relationship between types of common channel and development of biliary tract cancer in pancreaticobiliary maljunction.
Hara H; Morita S; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(44):322-5. PubMed ID: 11995442
[TBL] [Abstract][Full Text] [Related]
8. Clinical abnormalities in adults with pancreaticobiliary maljunction with and without bile-duct dilatation.
Tanaka K; Nishimura A; Ishibe R; Yoshimine M; Ogata S; Taira A
Can J Surg; 1995 Aug; 38(4):351-4. PubMed ID: 7634202
[TBL] [Abstract][Full Text] [Related]
9. Studies on biliary tract carcinoma in the case with pancreaticobiliary maljunction.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Otani M; Iwamoto M; Inoue H; Tanigawa N
Hepatogastroenterology; 2002; 49(43):104-8. PubMed ID: 11941930
[TBL] [Abstract][Full Text] [Related]
10. Late postoperative complications in patients with pancreaticobiliary maljunction.
Sakaguchi T; Suzuki S; Suzuki A; Fukumoto K; Jindo O; Ota S; Inaba K; Kikuyama M; Nakamura S; Konno H
Hepatogastroenterology; 2007 Mar; 54(74):585-9. PubMed ID: 17523327
[TBL] [Abstract][Full Text] [Related]
11. Pathological features and surgical outcome of pancreaticobiliary maljunction without dilatation of the extrahepatic bile duct.
Tsuchida A; Itoi T; Endo M; Kitamura K; Mukaide M; Itokawa F; Ozawa T; Aoki T
Oncol Rep; 2004 Feb; 11(2):269-76. PubMed ID: 14719053
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in pancreaticobiliary maljunction.
Matsumoto Y; Fujii H; Itakura J; Matsuda M; Nobukawa B; Suda K
J Hepatobiliary Pancreat Surg; 2002; 9(1):45-54. PubMed ID: 12021897
[TBL] [Abstract][Full Text] [Related]
13. Pancreaticobiliary maljunction and biliary cancer.
Kamisawa T; Kuruma S; Tabata T; Chiba K; Iwasaki S; Koizumi S; Kurata M; Honda G; Itoi T
J Gastroenterol; 2015 Mar; 50(3):273-9. PubMed ID: 25404143
[TBL] [Abstract][Full Text] [Related]
14. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union.
Tanno S; Obara T; Fujii T; Mizukami Y; Shudo R; Nishino N; Ura H; Klein-Szanto AJ; Kohgo Y
Cancer; 1998 Jul; 83(2):267-75. PubMed ID: 9669809
[TBL] [Abstract][Full Text] [Related]
15. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter bilis colonization of the biliary system in patients with pancreaticobiliary maljunction.
Kosaka T; Tajima Y; Kuroki T; Mishima T; Adachi T; Tsuneoka N; Fukuda K; Kanematsu T
Br J Surg; 2010 Apr; 97(4):544-9. PubMed ID: 20155791
[TBL] [Abstract][Full Text] [Related]
17. Pancreas divisum in pancreaticobiliary maljunction.
Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2008; 55(81):249-53. PubMed ID: 18507118
[TBL] [Abstract][Full Text] [Related]
18. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Iwamoto M; Tanigawa N
Hepatogastroenterology; 2001; 48(40):984-7. PubMed ID: 11490854
[TBL] [Abstract][Full Text] [Related]
20. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction.
Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F
J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
